Etomoxir is a selective inhibitor of the mitochondrial fatty acid transport protein, classified as an anti-obesity agent used in research to investigate metabolic regulation and the treatment of obesity… Read more
Etomoxir is a selective inhibitor of the mitochondrial fatty acid transport protein, classified as an anti-obesity agent used in research to investigate metabolic regulation and the treatment of obesity and related disorders. This category provides essential reference standards, including high-purity impurities and metabolites, designed to support rigorous impurity profiling and method validation in pharmaceutical development. Laboratories also utilize these compounds for quality control protocols, ensuring the accurate identification of degradants and synthesis by-products. Additionally, the collection includes stable isotope labelled compounds, such as deuterium and carbon-13 labelled variants, which serve as critical internal standards for precise quantification during pharmacokinetic studies and mass spectrometry-based analytical testing. By offering these high-quality reference materials, the catalogue facilitates reliable structural characterization and consistency throughout the drug development lifecycle.